Celldex Therapeutics
CLDX
CLDX
162 hedge funds and large institutions have $1.85B invested in Celldex Therapeutics in 2013 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 59 increasing their positions, 47 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% more funds holding
Funds holding: 150 → 162 (+12)
19% less capital invested
Capital invested by funds: $2.28B → $1.85B (-$431M)
Holders
162
Holding in Top 10
2
Calls
$42M
Puts
$30.7M
Top Buyers
| 1 | +$85M | |
| 2 | +$48.8M | |
| 3 | +$40.5M | |
| 4 |
O
OrbiMed
New York
|
+$31.7M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$31.1M |
Top Sellers
| 1 | -$31M | |
| 2 | -$27.9M | |
| 3 | -$23.8M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$16.1M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$12.6M |